Headlines about Marrone Bio Innovations (NASDAQ:MBII) have trended somewhat positive on Wednesday, according to Accern. Accern identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Marrone Bio Innovations earned a media sentiment score of 0.24 on Accern’s scale. Accern also assigned news headlines about the basic materials company an impact score of 45.2342259987361 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

These are some of the headlines that may have effected Accern’s rankings:

Separately, ValuEngine downgraded shares of Marrone Bio Innovations from a “sell” rating to a “strong sell” rating in a research note on Friday, September 1st. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $2.50.

Marrone Bio Innovations (MBII) traded down $0.02 during trading hours on Wednesday, hitting $1.08. 166,400 shares of the stock were exchanged, compared to its average volume of 95,859. Marrone Bio Innovations has a 1 year low of $0.85 and a 1 year high of $2.45. The company has a debt-to-equity ratio of -1.14, a quick ratio of 0.36 and a current ratio of 0.69.

COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://www.dailypolitical.com/2017/12/20/marrone-bio-innovations-mbii-receives-news-impact-rating-of-0-24.html.

About Marrone Bio Innovations

Marrone Bio Innovations, Inc offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene.

Insider Buying and Selling by Quarter for Marrone Bio Innovations (NASDAQ:MBII)

Receive News & Ratings for Marrone Bio Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations and related companies with MarketBeat.com's FREE daily email newsletter.